Dongsung Pharm Capital Reinvestment Ratio
Dongsung Pharm capital reinvestment ratio. Dongsung Pharm (002210) has a Capital Reinvestment Ratio of 0.54x as of December 2024, meaning it reinvests 1% of its operating cash flow (₩3.01 Billion) in capital expenditures (₩1.62 Billion). Check Dongsung Pharm total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Dongsung Pharm (2010–2020)
Capital reinvestment ratio of Dongsung Pharm from 2010 to 2020. This chart tracks Dongsung Pharm's Capital Reinvestment Ratio across 4 annual periods. Also explore Dongsung Pharm (002210) equity growth momentum to track the company's year-over-year net asset growth rate.
Dongsung Pharm Capital Reinvestment Ratio by Year (2010–2020)
Dongsung Pharm capital reinvestment ratio by year from 2010 to 2020. For the full cash flow conversion analysis, see Dongsung Pharm cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 1.38x | ₩5.01 Billion | ₩6.92 Billion | ▼ -9.5% |
| 2018 | 1.53x | ₩1.39 Billion | ₩2.13 Billion | ▼ -8.6% |
| 2017 | 1.67x | ₩1.80 Billion | ₩3.00 Billion | ▲ +626.3% |
| 2010 | 0.23x | ₩3.68 Billion | ₩847.33 Million | — |